Mickland, Inc. - FORM 10-Q

Attached files

file	filename
EX-31.1 - CERTIFICATION - Mickland, Inc.	corehcn_ex311.htm
EX-32.1 - CERTIFICATION - Mickland, Inc.	corehcn_ex321.htm

U. S. SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

Form 10-Q

(Mark One)


þ		QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2011


o		TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number

Core Health Care Network, Inc.

Formerly known as Mickland, Inc.

(Exact name of registrant as specified in its charter)

Nevada		26-3452407
(State or other jurisdiction of		(IRS Employer Identification No.)
incorporation or organization)

For correspondence, please contact:

Jillian Ivey Sidoti, Esq.

34721 Myrtle Court

Winchester, CA 92596

(323) 799-1342 (phone)

(951) 602-6049 (fax)

200 S. Virginia, 8th Floor - Reno, Nevada 89501

(Address of principal executive offices)

877.862.0061

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer o		Accelerated filer o		Non-accelerated filer o		Smaller reporting company þ
				(Do not check if a smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes þ No o

At May 23, 2011, there were 4,870,000 shares outstanding of the registrant’s common stock.

CORE HEALTH CARE NETWORK, INC.

INDEX TO FORM 10-Q

FOR THE QUARTER ENDED March 31, 2011

		Page Number
PART I. FINANCIAL INFORMATION

Item 1.	Financial Statements			F-1

	Balance Sheets as of March 31, 2011 and December 31, 2010			F-1

	Statements of Operations for the three months ended March 31, 2011 and 2010 and for the period from October 13, 2008 (date of inception) to March 31, 2011			F-2

	Statement of Stockholders’ Deficit as of March 31, 2011 Statements of Cash Flows for the three months ended March 31, 2011 and 2010 and for the period from			F-3

	October 13, 2008 (date of inception) to March 31, 2011			F-4

	Notes to Financial Statements		F-5 to F-12

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations			3

Item 3.	Controls and Procedures			10

PART II. OTHER INFORMATION

Item 1.	Legal Proceedings			12

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds			12

Item 3.	Defaults upon senior securities			12

Item 4.	Submissions of matters to a vote of securities holders			12

Item 5.	Other Information			12

Item 6.	Exhibits			12

	Exhibit 31.1

	Exhibit 32.1

PART I — FINANCIAL INFORMATION

Item 1. FINANCIAL STATEMENTS

CORE HEALTH CARE NETWORK, INC.

(FORMERLY MICKLAND, INC.)

(A DEVELOPMENT STAGE COMPANY)

BALANCE SHEETS

AS OF MARCH 31, 2011 AND DECEMBER 31, 2010

ASSETS	March 31, 2011			December 31, 2010

Current Assets
Cash and equivalents	$	162		$	150
Prepaid consulting		12,000			12,000
		12,162			12,150

Other Assets
Website domain names, net		1,000			1,000
Assignment – letter of intent		100,000			100,000
Total Other Assets		101,000			101,000

TOTAL ASSETS	$	113,162		$	113,150

LIABILITIES AND STOCKHOLDERS’ DEFICIT
Liabilities
Current Liabilities
Accrued expenses	$	77,258			50,189
Accrued expenses – related parties		48,620			24,222
Accrued interest – shareholders		3,754			1,955
Notes payable – shareholders		115,613			115,613
Total current liabilities		245,245			191,979

Stockholders’ Deficit
Preferred Stock, $.0001 par value, 10,000,000 shares authorized, -0- shares issued and outstanding		0			0
Common Stock, $.0001 par value, 100,000,000 shares authorized, 4,975,000 and 4,870,000 shares issued and outstanding, respectively		498			487
Additional paid-in capital		30,422			17,933
Deficit accumulated during the development stage		(163,003	)		(97,249	)
Total stockholders’ deficit		(132,083	)		(78,829	)

TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT	$	113,162		$	113,150

See accompanying notes to financial statements.

F- 1

CORE HEALTH CARE NETWORK, INC.

(FORMERLY MICKLAND, INC.)

(A DEVELOPMENT STAGE COMPANY)

STATEMENTS OF OPERATIONS

FOR THE THREE MONTHS ENDED MARCH 31, 2011 AND 2010

PERIOD FROM OCTOBER 13, 2008 (INCEPTION) TO MARCH 31, 2011

	Three months ended March 31, 2011			Three months ended March 31, 2010			Period from October 13, 2008 (inception) to March 31, 2011

REVENUES	$	0		$	0		$	0

OPERATING EXPENSES
Professional fees		2,000			1,000			29,869
Consulting fees		15,000			0			30,000
Directors’ fees		9,000			0			18,000
Investment expenses		692			0			5,692
Wages and taxes		36,049			0			72,050
Filing fees		333			0			1,800
General and administrative		881			165			1,837
TOTAL OPERATING EXPENSES		63,955			1,165			159,248

LOSS FROM OPERATIONS		(63,955	)		(1,165	)		(159,248	)

OTHER EXPENSES
Interest expense		1,799			249			3,755
TOTAL OTHER EXPENSES		1,799			249			3,755

NET LOSS BEFORE PROVISION FOR INCOME TAXES		(65,754	)		(1,414	)		(163,003	)

PROVISION FOR INCOME TAXES		0			0			0

NET LOSS	$	(65,754	)	$	(1,414	)	$	(163,003	)

NET LOSS PER SHARE: BASIC AND DILUTED	$	(0.01	)	$	(0.00	)

WEIGHTED AVERAGE SHARES OUTSTANDING: BASIC AND DILUTED		4,917,935			1,000,000

See accompanying notes to financial statements.

F- 2

CORE HEALTH CARE NETWORK, INC.

(FORMERLY MICKLAND, INC.)

(A DEVELOPMENT STAGE COMPANY)

STATEMENT OF STOCKHOLDERS’ DEFICIT

PERIOD FROM OCTOBER 13, 2008 (INCEPTION) TO MARCH 31, 2011

	Common Stock				Additional Paid in		Stock Subscription			Deficit Accumulated During the Development
	Shares		Amount		Capital		Receivable			Stage			Total

Issuance of common stock @ $.0001 at inception		1,000,000	$	100	$	0	$	(100	)	$	0		$	0

Net loss for the period ended December 31, 2008		-		-		-		-			(9,051	)		(9,051	)

Balance, December 31, 2008		1,000,000		100		0		(100	)		(9,051	)		(9,051	)

Cash received for stock subscription		-		-		-		100			-			100

Net loss for the year ended December 31, 2009		-		-		-		-			(7,272	)		(7,272	)

Balance, December 31, 2009		1,000,000		100		0		0			(16,323	)		(16,223	)

Shares issued for cash at $0.001 per share		570,000		57		513		-			-			570

Shares issued for cash at $0.05 per share		50,000		5		2,495		-			-			2,500

Shares issued for website domain names at $0.001 per share		1,000,000		100		900		-			-			1,000

Shares issued for debt conversion at $0.001 per share		2,250,000		225		2,025		-			-			2,250

Stock options issued for services		-		-		12,000		-			-			12,000

Net loss for the year ended December 31, 2010		-		-		-		-			(80,926	)		(80,926	)

Balance, December 31, 2010		4,870,000		487		17,933		0			(97,249	)		(78,829	)

Shares issued for cash @ $0.10 per share		50,000		5		4,995		-			-			5,000

Shares issued for cash at $0.50 per share		5,000		1		2,499		-			-			2,500

Shares issued for cash @ $0.10 per share		50,000		5		4,995		-			-			5,000

Net loss for the three months ended March 31, 2011		-		-		-		-			(65,754	)		(65,754	)

Balance, March 31, 2011		4,975,000	$	498		30,422	$	0		$	(163,003	)	$	(132,083	)

See accompanying notes to financial statements.

F- 3

CORE HEALTH CARE NETWORK, INC.

(FORMERLY MICKLAND, INC.)

(A DEVELOPMENT STAGE COMPANY)

STATEMENTS OF CASH FLOWS

FOR THE YEARS ENDED MARCH 31, 2011 AND 2010

PERIOD FROM OCTOBER 13, 2008 (INCEPTION) TO MARCH 31, 2011

	Three months ended March 31, 2011			Three months ended March 31, 2010			Period from October 13, 2008 (inception) to March 31, 2011
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss for the period	$	(65,754	)	$	(1,414	)	$	(163,003	)
Change in non-cash working capital items:
Increase (decrease) in accrued expenses and interest		27,069			(1,500	)		77,258
Increase in accrued expenses – related parties		24,398			0			48,620
Increase in accrued interest – related party		1,799			249			3,754
NET CASH USED IN OPERATING ACTIVITIES		(12,488	)		(2,665	)		(33,371	)

CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from notes payable – shareholder		0			2,665			17,863
Proceeds from sales of common stock		12,500			0			15,670
NET CASH PROVIDED BY FINANCING ACTIVITIES		12,500			2,665			33,533

NET INCREASE IN CASH		12			0			162

CASH, BEGINNING OF PERIOD		150			100			0
CASH, END OF PERIOD	$	162		$	100		$	162

SUPPLEMENTAL CASH FLOW INFORMATION
Interest paid	$	0		$	0		$	0
Income taxes paid	$	0		$	0		$	0

SUPPLEMENTAL NON-CASH INVESTING AND FINANCING INFORMATION
Shares issued to acquire website domain names	$	0		$	0		$	1,000
Issuance of note payable in connection with letter of intent to acquire Indian River Radiology, LLC	$	0		$	0		$	100,000
Conversion of debt to common stock	$	0		$	0		$	2,250
Stock options issued for future services and recorded as prepaid consulting	$	0		$	0		$	12,000

See accompanying notes to financial statements.

F- 4

CORE HEALTH CARE NETWORK, INC.

(FORMERLY MICKLAND, INC.)

(A DEVELOPMENT STAGE COMPANY)

NOTES TO THE FINANCIAL STATEMENTS

MARCH 31, 2011

NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Nature of Business

Core Health Care Network, Inc. (the “Company or “Core”) is a development stage company and was incorporated in Nevada on October 13, 2008. The Company’s objective is to acquire operating healthcare related businesses in a business combination.

Development Stage Company

The accompanying financial statements have been prepared in accordance with generally accepted accounting principles related to development stage companies. A development-stage company is one in which planned principal operations have not commenced or if its operations have commenced, there has been no significant revenues there from.

Basis of Presentation

The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America and are presented in U.S. dollars.

Accounting Basis

The Company uses the accrual basis of accounting and accounting principles generally accepted in the United States of America (“GAAP” accounting). The Company has adopted a December 31 fiscal year end.

F- 5

Cash and Cash Equivalents

The Company considers all highly liquid investments with the original maturities of three months or less to be cash equivalents. The Company had $162 and $150 of cash as of March 31, 2011 and December 31, 2010, respectively.

Reclassifications

Certain accounts and financial statement captions in the prior periods have been reclassified to conform to the current period financial statements.

Income Taxes

Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized.

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Revenue Recognition

The Company recognizes revenue when products are fully delivered or services have been provided and collection is reasonably assured.

F- 6

CORE HEALTH CARE NETWORK, INC.

(FORMERLY MICKLAND, INC.)

(A DEVELOPMENT STAGE COMPANY)

NOTES TO THE FINANCIAL STATEMENTS

MARCH 31, 2011

NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Advertising Costs

The Company’s policy regarding advertising is to expense advertising when incurred. The Company incurred advertising expense of $0 and $0 during the periods ended March 31, 2011 and 2010, respectively.

Stock-Based Compensation

Stock-based compensation is accounted for at fair value in accordance with ASC Topic 718. To date, the Company has not adopted a stock option plan and has not granted any stock options.

Basic Income (Loss) Per Share

Basic income (loss) per share is calculated by dividing the Company’s net loss applicable to common shareholders by the weighted average number of common shares during the period. Diluted earnings per share is calculated by dividing the Company’s net income available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. There are no such common stock equivalents outstanding as of March 31, 2011.

F- 7

Comprehensive Income

The Company has which established standards for reporting and display of comprehensive income, its components and accumulated balances. When applicable, the Company would disclose this information on its Statement of Stockholders’ Equity. Comprehensive income comprises equity except those resulting from investments by owners and distributions to owners. The Company has not had any significant transactions that are required to be reported in other comprehensive income.

Recent Accounting Pronouncements

Core does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company’s results of operations, financial position or cash flow.

NOTE 2 – PREPAID CONSULTING

On November 17, 2010, the Company granted 200,000 stock options for consulting services valued at $12,000. The services had not occurred as of March 31, 2011 and the amount has been recorded as prepaid consulting. The options have an exercise price of $0.05 with 100,000 options expiring on November 17, 2011 and the remaining 100,000 options expiring on November 17, 2012. The consulting expenses are expected to occur during 2011.

NOTE 3 – ASSIGNMENT OF ACQUISITION

On December 1, 2010, the Company acquired a letter of intent from ACE Diagnostics, LLC, a shareholder of the Company, for $100,000. ACE Diagnostics, LLC had earlier entered into the letter of intent with Indian River Radiology to acquire the majority of the assets of Indian River Radiology. In the event that the acquisition is completed, the amount of the note will be applied towards the purchase price. See Note 7.

F- 8

CORE HEALTH CARE NETWORK, INC.

(FORMERLY MICKLAND, INC.)

(A DEVELOPMENT STAGE COMPANY)

NOTES TO THE FINANCIAL STATEMENTS

MARCH 31, 2011

NOTE 4 – WEBSITE DOMAIN NAMES

During the year ended March 31, 2011, the Company acquired two website domain names in exchange for 1,000,000 shares of common stock valued at $0.001 per share for a total amount of $1,000. The domain names have an indefinite useful life and will be tested for impairment annually. No impairment charge was taken during the year ended March 31, 2011.

NOTE 5 – ACCRUED EXPENSES

Accrued expenses and interest consisted of the following at March 31, 2011 and December 31, 2010:

	2011		2010
Accrued professional fees	$	4,875	$	11,375
Accrued wages and taxes		72,050		36,001
Accrued investment expenses		0		2,500
Accrued general and administrative expenses		333		313
Total accrued expenses	$	77,258	$	50,189

NOTE 6 – ACCRUED EXPENSES – RELATED PARTIES

Accrued expenses – related parties consisted of the following at March 31, 2011 and December 31, 2010:

	2011		2010
Accrued consulting fees - shareholder	$	30,000	$	15,000
Accrued directors’ fees		18,000		9,000
Accrued shareholder expense reimbursement		620		222
Total accrued expenses	$	48,620	$	24,222

NOTE 7 – NOTES PAYABLE – SHAREHOLDERS

The Company has received various loans from Loftum, LLC totaling $17,863 as of March 31, 2011 and December 31, 2010. The notes are unsecured, due on demand and bear interest at the rate of 8%. Loftum, LLC is a shareholder of the Company. Interest expense was $352 for the three months ended March 31, 2011. The balance due to the shareholder was $17,863 as of March 31, 2011. Accrued interest on this note was $2,308 and $1,955 as of March 31, 2011 and December 31, 2010, respectively.

Additionally, on December 1, 2010, the Company acquired a letter of intent from ACE Diagnostics, LLC. ACE Diagnostics is a shareholder of the Company. The letter of intent required a note be issued in the amount of $100,000. The loan is unsecured, bears 6% interest beginning on January 1, 2011, and is due on demand. On December 20, 2010, the Company converted $2,250 of the note to 2,250,000 shares of common stock. The balance due to the shareholder was $97,750 as of March 31, 2011 and December 31, 2010. Interest expense for the three months ended March 31, 2011 was $1,446. Accrued interest on this note was $1,446 at March 31, 2011.

F- 9

CORE HEALTH CARE NETWORK, INC.

(FORMERLY MICKLAND, INC.)

(A DEVELOPMENT STAGE COMPANY)

NOTES TO THE FINANCIAL STATEMENTS

MARCH 31, 2011

NOTE 8 – STOCKHOLDERS’ DEFICIT

The Company has 100,000,000 shares of par value $0.0001 common stock authorized. The Company also has 10,000,000 shares of par value $0.0001 preferred stock authorized.

At inception, the Company issued 1,000,000 shares of common stock at par value for cash proceeds of $100.

On August 10, 2010, the Company issued 500,000 shares of common stock at $0.001 per share for cash proceeds of $500.

Also on August 10, 2010, the Company issued 1,000,000 shares of common stock at $0.001 per share to acquire two website domain names valued at $1,000. See Note 3.

On November 16, 2010, the Company issued 70,000 shares of common stock at $0.001 per share for cash proceeds of $70.

On November 17, 2010, the Company issued 50,000 shares of common stock at $0.05 per share for cash proceeds of $2,500.

On November 17, 2010, the Company granted 200,000 stock options for consulting services valued at $12,000. The options have an exercise price of $0.05 with 100,000 options expiring on November 17, 2011 and the remaining 100,000 options expiring on November 17, 2012. See Note 2.

On December 20, 2010, the Company issued 2,250,000 shares of common stock at $0.001 per share to convert $2,250 of the ACE Diagnostics, LLC shareholder note payable. See Note 6.

On January 10, 2011, the Company entered into a stock purchase agreement to acquire 100% of the issued and outstanding stock of Med-Tech Corporation in exchange for 1,500,000 shares of the Core’s common stock. On April 29, 2011, the agreement was canceled. The shares were never issued and shall not be issued. See Note 12.

During the three months ended March 31, 2011, the Company sold 105,000 shares of its common stock at prices ranging from $0.10 to $0.50 per share.

There were 4,975,000 shares of common stock outstanding as of March 31, 2011. There are no shares of preferred stock outstanding as of March 31, 2011.

NOTE 9 – COMMITMENTS

Core Health Care Network, Inc. rented office space beginning on December 1, 2010 for approximately $79 per month on a month to month basis.

Prior to December 1, 2010, an officer had provided office services without charge. Such costs are immaterial to the financial statements and accordingly are not reflected herein. The officers and directors are involved in other business activities and most likely will become involved in other business activities in the future.

F- 10

CORE HEALTH CARE NETWORK, INC.

(FORMERLY MICKLAND, INC.)

(A DEVELOPMENT STAGE COMPANY)

NOTES TO THE FINANCIAL STATEMENTS

MARCH 31, 2011

NOTE 10 – INCOME TAXES

For the period ended March 31, 2011, the Company has incurred net losses and, therefore, has no tax liability. The net deferred tax asset generated by the loss carry-forward has been fully reserved. The cumulative net operating loss carry-forward is approximately $163,000 at March 31, 2011, and will expire beginning in the year 2028.

The provision for Federal income tax consists of the following as of March 31, 2011 and 2010:

	2011			2010
Federal income tax benefit attributable to:
Current operations	$	22,356		$	481
Less: valuation allowance		(22,356	)		(481	)
Net provision for Federal income taxes	$	0		$	0

The cumulative tax effect at the expected rate of 34% of significant items comprising our net deferred tax amount is as follows at March 31, 2011 and December 31, 2010:

	2011			2010
Deferred tax asset attributable to:
Net operating loss carryover	$	55,421		$	33,057
Valuation allowance		(55,421	)		(33,057	)
Net deferred tax asset	$	0		$	0

NOTE 11 – LIQUIDITY AND GOING CONCERN

Core Health Care Network, Inc. has negative working capital, has incurred operating losses since inception, and has not yet received revenues from sales of products or services. These factors create substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustment that might be necessary if the Company is unable to continue as a going concern.

The ability of the Company to continue as a going concern is dependent on the Company generating cash from the sale of its common stock and/or obtaining debt financing and attaining future profitable operations. Management’s plans include selling its equity securities and obtaining debt financing to fund its capital requirement and ongoing operations; however, there can be no assurance the Company will be successful in these efforts.

NOTE 12 – SUBSEQUENT EVENTS

On January 10, 2011, Core Health Care Network, Inc. (“CORE”) and Med-Tech, Inc. (“Med-Tech”) (collectively, “the Parties”) entered into the Stock Purchase Agreement (the “Agreement”) where Core acquired 100% of the stock of Med-Tech. The transaction closed on February 12, 2011. On April 29, 2011, the same parties entered into a Rescission Agreement in the which they agreed to rescind, annul and abrogate the Agreement and make it void from its inception. A copy of the Agreement is filed as an exhibit to this filing.

All Shares exchanged as consideration for the transaction have been returned to each Company. No money was exchanged. Core and Med-Tech makes no claim to any of the shares of returned.

F- 11

CORE HEALTH CARE NETWORK, INC.

(FORMERLY MICKLAND, INC.)

(A DEVELOPMENT STAGE COMPANY)

NOTES TO THE FINANCIAL STATEMENTS

MARCH 31, 2011

NOTE 12 – SUBSEQUENT EVENTS (CONTINUED)

In accordance with SFAS 165 (ASC 855-10) the Company has analyzed its operations subsequent to March 31, 2011 to May 15, 2011, the date these financial statements were issued, and has determined that it does not have any material subsequent events to disclose in these financial statements other than those discussed above.

F- 12

Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis should be read in conjunction with the consolidated financial statements and related notes included in this report and those in our 10-k filed with the Securities and Exchange Commission on April 15, 2011 and our 8-k filed on May 5, 2011. This discussion contains forward-looking statements that involve risks and uncertainties. Our actual results may differ materially from those anticipated in such forward-looking statements as a result of certain factors, including but not limited to, those described under “Risk Factors” included in Part II, Item IA of this report.

Overview

CORE HEALTH CARE NETWORK, INC. (“we”, “us”, the “Company” or like terms) was incorporated in the State of Nevada on October 13, 2008 as Mickland, Inc. We are a developmental stage company and have not generated any revenues to date. Since inception, we have not engaged in any business operations other than in connection with our organization and the preparation and filing of this registration statement on Form 10 (the “Registration Statement”). We have no full-time employees and do not own or lease any property.

We were organized to serve as a vehicle for a business combination through a merger, capital stock exchange, asset acquisition or other similar business combination (a “Business Combination”) with an operating or development stage business (the “Target Business”) which desires to utilize our status as a reporting company under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

Given that we have no assets, no current operations and our proposed business contemplates entering into a Business Combination with an operating company or purchasing an operating company, we are a “shell company,” which is defined in Rule 405 under the Securities Act of 1933, as amended (the “Securities Act”), as a company which has (i) no or nominal operations; and (ii) either (x) no or nominal assets; (y) assets consisting solely of cash and cash equivalents; or (z) assets consisting of any amount of cash and cash equivalents and nominal other assets.

Although we do not have any Business Combinations under consideration, we plan to own various specialty healthcare companies with a focus on diagnostic and preventive health products and services. The Healthcare sector, specifically the physician segment and ancillary services provide significant opportunity for the outsourcing of medical imaging and diagnostic services, information technology, billing, and practice management functions. In response to this demand Company plans to develop “CORE Health Care Network” that will consist of a) Diagnostic Testing Facilities; b)Healthcare Providers, mainly Primary Care Physicians in either solo practice or small practices of five (5) physicians or less; and c) Vendors of goods and services

Results of Operations for the Quarter ending March 31, 2011

Assets

Currently, we have $162 in cash and $12,000 pre-paid consulting services as our only assets.

Operating Expense

Total operating expenses for the three months ended March 31, 2011 were $63,955 compared to expenses for the period ended March 31, 2011 of $159,248 since inception and $1,165 for the three months ended March 31, 2010.

Net Loss

Net loss for the three months ended March 31, 2011 was $(65,754) and $(1,414) for the three months ended March 31, 2010 compared to the period ended March 31, 2011 since inception of $(163,003).

Liquidity and Capital Resources

At March 31, 2011, we had $162 in cash.

Critical Accounting Policies and Estimates

Our critical accounting policies are disclosed in our Form 10 Registration Statement. During the three months ended March 31, 2011 there have been no significant changes in our critical accounting policies.

Recent Accounting Pronouncements

Recent accounting pronouncements are disclosed in our Form 10 Registration Statement, filed with the Securities and Exchange Commission on July 6, 2009. During the three months ended March 31, 2011 there have been no new accounting pronouncements which are expected to significantly impact our consolidated financial statements.

PLAN OF OPERATION AND LIQUIDITY

In August, 2010, we changed our name from Mickland, Inc. to Core Health Network, Inc. However, this has not resulted in a Business Combination and Core Health Care Network was not a Target Business. With this name change, we also issued 1,500,000 shares of stock to our new officers and directors. Please see our 8-K filed on August 2, 2010.

We are not presently engaged in, and we will not engage in, any substantive commercial business for an indefinite period until we identify a Target Business and enter into a Business Combination, if ever. On February 22, 2011, we filed a Form 8-K announcing our merger with MedTech, Inc. However, it was later realized that the agreement may have been entered into under false pretenses on the behalf of the officer of MedTech. On May 5, 2011, we filed an 8-k with the Commission rescinding the agreement with MedTech.

In October, 2010, we officially entered into employment agreements with our Secretary and Treasurer, Pam McClanahan, at a rate of $3,500 per month. We also entered into an employment agreement with our President, Lewis Warren, at a rate of $7,500. Due to a lack of capital, neither individual has been paid and their payments are accruing as liabilities.

We also entered into a consulting agreement with FTH Group which is controlled by our board member, Mr. F. Tony Hosseini. FTH Group is assisting with development of the business and searching to a possible business combination. A Business Combination may involve the acquisition of, or merger with, a company which desires to have a class of securities registered under the Exchange Act, while avoiding what it may deem to be adverse consequences of undertaking a public offering itself. These include time delays, significant expenses, possible loss of voting control and compliance with various federal and state securities laws. As more fully described below under the heading “Form of acquisition; Opportunity for stockholder approval,” the proposed structure of any Business Combination may not require that we seek stockholder approval for the transaction and holders of our common stock may not have the opportunity to vote upon any such Business Combination.

On November 17, 2010, we entered into an agreement with Dr. H. Paul Hatten, who is also a shareholder of the Company, as a medical advisor. Dr. Hatten has received 200,000 exercisable at $0.05 per share for services valued at $12,000. 100,000 options expire on November 1, 2011 and the remaining options expire on November 17, 2012.

Transfer of Domains and Website Development.

Mr. Hosseini and Mr. Warren, in exchange for 500,000 shares each at $.0001 per share (total of $1,000), transferred two websites to the company for future company use and development. The websites are corehcn.com and corehealthtrack.com.

Assignment of Indian River Agreement.

On December 20, 2010, ACE Diagnostics, LLC (“ACE”), a company managed by our shareholder, F. Tony Hosseini, assigned their interest in a letter of intent between ACE and Indian River Radiology, Inc. (“Indian River”) for ACE to acquire Indian River. In exchange for the assignment and for the efforts put forth with the potential acquisition of ACE, the Company entered into a promissory note with ACE for $100,000 at a rate of 6% per annum. This note is due upon demand.

There is no guarantee that the Company will acquire Indian River or that any kind of final agreement will be consummated.

We have not identified a target business or target industry.

To date, we have not selected any Target Business, but plan to limit our search within the health care industry with a focus on diagnostic and preventive health products and services. We have not conducted any research with respect to identifying the number and characteristics of the potential Target Business candidates. As a result, we cannot assure you that we will be able to locate a Target Business or that we will be able to engage in a Business Combination with a Target Business on favorable terms.

We will have virtually unrestricted flexibility in identifying and selecting a prospective Target Business. We have not established any specific attributes or criteria (financial or otherwise) for prospective Target Businesses. To the extent we affect a Business Combination with a financially unstable company or an entity in its early stage of development or growth, including entities without established records of sales or earnings, we may be affected by numerous risks inherent in the business and operations of financially unstable and early stage or potential emerging growth companies. Although our management will endeavor to evaluate the risks inherent in a particular Target Business, we cannot assure you that we will properly ascertain or assess all significant risk factors.

Sources of target businesses.

Management expects that Target Business candidates could be brought to our attention from various unaffiliated sources, including members of the financial community, as well as accountants and attorneys who represent potential Target Business candidates. Target Business candidates may be brought to our attention by these unaffiliated sources as a result of being solicited by us through calls or mailings. These sources may also introduce us to Target Businesses candidates they think we may be interested in on an unsolicited basis. Our officers and directors, as well as their affiliates, may also bring to our attention Target Business candidates of which they become aware through their business contacts, as a result of formal or informal inquiries or discussions they may have, as well as attending trade shows or conventions. In no event will our existing officers and directors or stockholders, or any entity with which any of them is affiliated, be paid any finder’s fee, consulting fee or other compensation prior to, or for any services they may render in order to effectuate, the consummation of a Business Combination. After the effective date of this Registration Statement, we may engage the services of professional firms or other individuals that specialize in business acquisitions, in which event we may pay a finder’s fee, consulting fee or other compensation to be determined in an arm’s length negotiation. We have not adopted any policies with respect to utilizing the services of consultants or advisors to assist in the identification of a Target Business, the criteria to be used in selecting such consultants or advisors, the services to be provided, the term of service, or regarding the total amount of fees that may be paid. However, because of our limited resources, it is likely that any such fee we agree to pay would be paid in shares of our common stock.

Selection criteria of a Target Business.

Our management will have virtually unrestricted flexibility in identifying and selecting a prospective Target Business. We have not established any specific attributes or criteria (financial or otherwise) for prospective Target Businesses. In evaluating a prospective Target Business, our management will consider, among other factors, the following:

·	financial condition and results of operations;
·	growth potential;
·	experience and skill of management and availability of additional personnel;

·	capital requirements;
·	competitive position;
·	barriers to entry;
·	stage of development of the products, processes or services;
·	degree of current or potential market acceptance of the products, processes or services;
·	proprietary features and degree of intellectual property or other protection of the products, processes or services;
·	regulatory environment of the industry; and
·	costs associated with affecting the Business Combination.

These criteria are not intended to be exhaustive or to in any way limit the board of director’s unrestricted discretion to enter into a Business Combination with any Target Business. Any evaluation relating to the merits of a particular Business Combination will be based, to the extent relevant, on the above factors as well as other considerations deemed relevant by our management. In evaluating a prospective Target Business, we will conduct as extensive a due diligence review of potential targets as possible given the lack of information which may be available regarding private companies, our limited personnel and financial resources and the inexperience of our management with respect to such activities. We expect that our due diligence will encompass, among other things, meetings with the Target Business’s incumbent management and inspection of its facilities, as well as a review of financial and other information which is made available to us. This due diligence review will be conducted either by our management or by unaffiliated third parties we may engage. Our limited funds and the lack of full-time management will likely make it impracticable to conduct a complete and exhaustive investigation and analysis of a Target Business candidate before we consummate a Business Combination. Management decisions, therefore, will likely be made without detailed feasibility studies, independent analysis, market surveys and the like which, if we had more funds available to us, would be desirable. We will be particularly dependent in making decisions upon information provided by the promoters, owners, sponsors, or others associated with the Target Business seeking our participation.

The time and costs required to select and evaluate a Target Business and to structure and complete the Business Combination cannot presently be ascertained with any degree of certainty. Any costs incurred with respect to the identification and evaluation of a prospective Target Business with which a Business Combination is not ultimately completed will result in a loss to us.

Lack of diversification.

In the initial stages of our business development, the prospects for our success may be entirely dependent upon the future performance of a single business and we will not benefit from the possible spreading of risks or offsetting of losses. By consummating a Business Combination with a single entity, our lack of diversification may:

·	subject us to numerous economic, competitive and regulatory developments, any or all of which may have a substantial adverse impact on the company, and

·	result in our dependency upon the development or market acceptance of a single or limited number of products, processes or services.

Limited ability to evaluate the Target Business.

To a significant degree, our security holders will rely on management’s evaluation of a Target Business in making the decision to enter into a Business Combination. Management’s assessment of a Target Business will be based upon discussions with management of the Target Business and a review of due diligence material relating to the Target Business available to it during the evaluation period. Any such assessment may not be accurate.

Although we intend to scrutinize the management of a prospective Target Business when evaluating the desirability of effecting a Business Combination, we cannot assure you that our assessment of the Target Business’s management will prove accurate.

Given our current resources, we will likely seek a Business Combination with a privately-held company that is in the healthcare industry and focuses on diagnostic and preventive health products and services. Generally, very little public information exists about these companies and we will be required to rely on the ability of our management to obtain adequate information to evaluate the potential returns from entering into a Business Combination with such a company. If we do not uncover all material information about a Target Business prior to a Business Combination, we may not make a fully informed investment decision and we may lose money on our investment.

Form of acquisition; Opportunity for stockholder approval.

The manner in which we participate in a Business Combination will depend upon, among other things, the nature of the opportunity and the respective requirements and desires of management of our Company and of the Target Business. In addition, the structure of any Business Combination will be dispositive as to whether stockholder approval of the Business Combination is required.

It is likely that we will acquire our participation in a business opportunity by the acquisition of Target Company through the issuance of our common stock or other securities to the principals of the Target Business in exchange for all or part of the outstanding stock of the Target Company. In the case of an acquisition, the transaction may be accomplished in the sole determination of management without any vote or approval by stockholders.

Although the terms of an acquisition of a Target Business cannot be predicted, it is likely that we will seek to structure a Business Combination to qualify as a tax free transaction under the Internal Revenue Code of 1986, as amended (the "Code"). One such form of “tax free” transaction, if structured properly, entails the exchange of capital stock of the Target Business for our capital stock. Under Section 368(a)(1) of the Code, in order for a stock exchange transaction to qualify as a "tax free" reorganization, the holders of the stock of the target must receive a number of shares of our capital stock equal to 80% or more of the voting stock of our Company. If a transaction were structured to take advantage of these provisions rather than other "tax free" provisions provided under the Code, our existing stockholders would in such circumstances retain 20% or less of the total issued and outstanding shares of the surviving entity. Depending upon the relative negotiating strength of the parties, stockholders at the time of the Business Combination may retain substantially less than 20% of the total issued and outstanding shares of our Company. This could result in substantial additional dilution to the equity of those persons who were stockholders of our Company prior to such Business Combination.

In the case of a statutory merger or consolidation directly involving the Company, it might be necessary to call a stockholders' meeting and obtain the approval of the holders of a majority of the outstanding shares of common stock. The necessity to obtain stockholder approval may result in delay and additional expense in the consummation of any proposed transaction, which we may not be able to fund, and will also give rise to certain appraisal rights to dissenting stockholders. Accordingly, management will seek to structure any Business Combination so as not to require stockholder approval.

In the case of either an acquisition or merger, our stockholders prior to the consummation of a Business Combination likely will not have control of a majority of the voting shares of the Company following a Business Combination. As part of such a transaction, all or a majority of the Company's then director(s) may resign and new directors may be appointed without any vote by stockholders.

It is anticipated that the investigation of specific business opportunities and the negotiation, drafting and execution of relevant agreements, disclosure documents and other instruments will require substantial management time and attention and substantial cost for accountants, attorneys and others. If a decision is made not to participate in a specific business opportunity, the costs incurred in the related investigation would not be recoverable. Furthermore, even if an agreement is reached for a Business Combination, the failure to consummate that transaction may result in the loss to the Company of the related costs incurred.

Competition.

Our ability to consummate a Business Combination will be constrained by our lack of financial resources to provide to the Target Business. We expect that in the course of identifying, evaluating and selecting a Target Business, we may encounter intense competition from other entities having a business objective similar to ours. These include blank check companies that may have raised significant sums through sales of securities registered under federal securities laws that are seeking to carry out a business plan similar to ours and possess a significant competitive advantage over us both from a financial and personnel perspective. Additionally, we may be subject to competition from entities other than blank check companies having a business objective similar to ours, including venture capital firms, leverage buyout firms and operating businesses looking to expand their operations through acquisitions. Many of these entities are well established and have extensive experience identifying and affecting business combinations directly or through affiliates. Moreover, nearly all of these competitors possess greater technical, human and other resources than us. In addition, we will experience competition from other modestly capitalized shell companies that are seeking to enter into business combinations with targets similar to those we expect to pursue.

While we believe there may be numerous potential target candidates with which we could affect a Business Combination, our ability to compete in affecting a Business Combination with prime candidates will be limited by our lack of financial resources. This inherent competitive limitation gives others an advantage in pursuing the acquisition of a Target Business.

If we succeed in effecting a Business Combination, there will be, in all likelihood, intense competition from competitors of the Target Business. We cannot assure you that, subsequent to a Business Combination, we will have the resources or ability to compete effectively.

Employees.

We have two executive officers and three directors and they have other business interests and are not obligated to devote any specific number of hours to our matters and intends to devote only as much time as he deems necessary to our affairs. The amount of time they will devote to our operations in any time period will vary based on whether a Target Business has been selected for the Business Combination and the stage of the Business Combination process the Company is in. Accordingly, once management locates a suitable Target Business, management will spend more time investigating such Target Business and negotiating and processing the Business Combination (and consequently spend more time to our affairs) than they would prior to locating a suitable Target Business. We do not intend to have any full time employees prior to the consummation of a Business Combination.

Our officers and directors may engage in other business activities similar and dissimilar to those we are engaged in without any limitations or restrictions applicable to such activities. To the extent that our management engages in such other activities, he will have possible conflicts of interest in diverting opportunities which would be appropriate for our Company to other companies, entities or persons with which he is or may be associated or have an interest, rather than diverting such opportunities to us. Since we have not established any policy for the resolution of such a conflict, we could be adversely affected should our officers and directors choose to place their other business interests before ours. We cannot assure you that such potential conflicts of interest will not result in the loss of potential opportunities or that any conflict will be resolved in our favor.

Periodic Reporting and Audited Financial Statements; Disclosure of Business Combination.

Upon the effective date of this Registration Statement, our class of common stock will be registered under the Exchange Act and we will have reporting obligations, including the requirement that we file annual, quarterly and current reports with the SEC. In accordance with the requirements of the Exchange Act, our annual reports will contain financial statements audited and reported on by our independent registered public accountants.

We will not acquire a Target Business if audited financial statements based on United States generally accepted accounting principles cannot be obtained for the Target Business. We cannot assure you that any particular Target Business identified by us as a potential acquisition candidate will have financial statements prepared in accordance with United States generally accepted accounting principles or that the potential Target Business will be able to prepare its financial statements in accordance with United States generally accepted accounting principles. To the extent that this requirement cannot be met, we may not be able to acquire the proposed Target Business. While this may limit the pool of potential acquisition candidates, we do not believe that this limitation will be material.

Upon the consummation of a Business Combination, the Company will file with the Securities and Exchange Commission a current report on Form 8-K to disclose the Business Combination, the terms of the transaction and a description of the business and management of the Target Business, among other things, and will include audited consolidated financial statements of the Company giving effect to the Business Combination. Holders of the Company’s securities will be able to access the Form 8-K and other filings made by the Company on the EDGAR Company Search page of the Securities and Exchange Commission’s Web site, the address for which is “www.sec.gov.”

Item 3. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

The Company carried out an evaluation of the effectiveness of the design and operation of its disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of March 31, 2011. This evaluation was accomplished under the supervision and with the participation of our chief executive officer / principal executive officer, and chief financial officer / principal financial officer who concluded that our disclosure controls and procedures are currently effective to ensure that all material information required to be filed in the quarterly report on Form 10-Q has been made known to them.

For purposes of this section, the term disclosure controls and procedures means controls and other procedures of an issuer that are designed to ensure that information required to be disclosed by the issuer in the reports that it files or submits under the Act (15 U.S.C. 78a et seg.) is recorded, processed, summarized and reported, within the time periods specified in the Commission’s rules and forms. Disclosure, controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by in our reports filed under the Securities Exchange Act of 1934, as amended (the "Act") is accumulated and communicated to the issuer's management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Based upon an evaluation conducted for the period ended March 31, 2011, our Chief Executive Officer and Chief Financial Officer as of March 31, 2011, and as of the date of this Report, have concluded that as of the end of the periods covered by this report, they have identified no material weakness of Company internal controls.

Corporate expenses incurred are processed and paid by the officers of the Company. The current number of transactions is not sufficient to justify the retaining of additional accounting personnel.

Management’s Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act. Our internal control system was designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes, in accordance with generally accepted accounting principles in the United States of America. Our internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with accounting principles generally accepted in the United States of America, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management of the Company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the financial statements.

Because of inherent limitations, a system of internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate due to change in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Our management conducted an evaluation of the effectiveness of our internal control over financial reporting using the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control—Integrated Framework. Based on its evaluation, our management concluded that, as of March 31, 2011, our internal control over financial reporting was effective.

This quarterly report does not include an attestation report of the Company’s registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to the attestation by the Company’s registered public accounting firm pursuant to temporary rules of the SEC that permit the Company to provide only management’s report in this quarterly report.

Changes in Internal Controls over Financial Reporting

We have not yet made any changes in our internal controls over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1. LEGAL PROCEEDINGS

None

Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None

Item 3. DEFAULTS UPON SENIOR SECURITEIES

None

Item 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

None

Item 5. OTHER INFORMATION

None

Item 6. EXHIBITS

(a) Exhibits:


Number		Description

	31.1	Certification of Chief Executive and Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. (Filed herewith.)

	32.1	Certification of Chief Executive and Financial Officer pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (Filed herewith.)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	Core Health Care Network, Inc.

Date: May 23, 2011	By:	/s/ Lewis C. Warren
		President and Director
		Name: Lewis C. Warren
		(Principal Executive Officer)


Date: May 23, 2011	By:	/s/ Pamela McClanahan
		Secretary, Treasurer ,and Chief Financial Officer
		Name: Pamela McClanahan
		(Principal Financial Officer, and Principal Accounting Officer)

Mickland, Inc. - FORM 10-Q - May 23, 2011

Attached files

Mickland, Inc. Reports